Circulating plasma biomarkers in biopsy-confirmed kidney disease
Clinical Journal of the American Society of Nephrology Nov 16, 2021
Schmidt I, Mothi SS, Wilson P, et al. - This study unveiled various plasma protein biomarkers related to kidney disease histopathology as well as adverse clinical results in people with a diverse set of kidney diseases.
In this prospective cohort analysis of 549 persons with biopsy-verified kidney diseases and semi-quantitative assessment of histopathology, a multi-marker panel of 225 circulating plasma proteins was measured via a proteomics assay.
Experts identified 57 proteins were linked with different histopathologic lesions, after multivariable adjustment and correction for multiple testing.
Kidney injury molecule-1 and V-set and immunoglobulin domain-containing protein 2 were revealed as the top performing markers positively related to acute tubular injury and interstitial fibrosis and tubular atrophy, respectively.
There were 30 proteins that were significantly related to kidney disease progression and 35 were associated with death.
Placental growth factor (HR per doubling 5.4) and BMP and Activin Membrane Bound Inhibitor (HR 3.0) were the top performing markers for kidney disease progression.
For death, the top performing markers included TRAIL-receptor-2 (HR 2.9) and CUB Domain Containing Protein-1 (HR 2.4).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries